FDA approves Orexigen's weight-loss drug

September 11, 2014 1:29 PM

8 0

FDA approves Orexigen's weight-loss drug

The U.S. Food and Drug Administration said it approved Orexigen Therapeutics Inc.'s weight-loss treatment Contrave, the third such drug to receive the agency's approval in recent years.

Contrave has been approved as a treatment for chronic weight management in addition to a reduced-calorie diet and physical activity, the FDA said Wednesday in a statement on its website.

Also read: Ericsson Pushed to Hefty Loss by Write-Downs, Restructuring Costs

Read more

To category page